Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of palonosetron doses vs ondansetron + dexamethasone for prevention of postoperative nausea and vomiting in middle ear surgery
TCTR20260411003Phase 3Not yet recruiting
- Sponsor
- N/A
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of palonosetron, ondansetron, dexamethasone in postoperative nausea and vomiting (PONV), sponsored by N/A. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
palonosetronondansetrondexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on TCTR20260411003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260411003.